Location: | Manchester, Hybrid |
---|---|
Salary: | £32,000 to £36,000 |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 16th July 2024 |
---|---|
Closes: | 11th August 2024 |
Job Ref: | MI/24/38 |
Duration: Fixed term until 1 September 2025
We are recruiting for a Clinical Trial Coordinator maternity cover role within the Digital Cancer Research (DCR) team in the CRUK National Biomarker Centre in the CRUK Manchester Institute. The aim of the Clinical trial coordinator post is to be responsible for the day-to-day running of the technology clinical trials. This includes ensuring that regulatory and operational commitments are met, to ensure the smooth set-up and running of clinical trials. The post holder, as part of the DCR team, will work with teams across; The University of Manchester, The Christie R&D, ECMT Research Management Team, and other collaborating Institutions to deliver the portfolio of technology clinical trials.
The post is within the DCR’s technology clinical trials sub-team. As a member of the Technology Clinical Trials sub-team, this role will work to deliver clinical trials of innovative technologies, where patients are co-investigators in their own research.
You will:
Background:
The DCR sits at the interface between cancer research and new emerging analytical and digital methodologies. The goal of the team is to use innovative technologies to improve cancer care. We enable patients to play a more active role in their clinical trial participation by using digital technologies; create digital tools to allow clinicians to visualise and analyse clinical trial data, and use cutting edge AI technologies to enhance biomarker discovery and augment clinical trials.
About you:
You should have a degree in a scientific discipline or other relevant subject, and significant relevant experience, or a relevant postgraduate qualification, along with:
Why choose CRUK National Biomarker Centre?
The Cancer Research UK National Biomarker Centre is a leading and highly specialised translational research centre within The University of Manchester (www.manchester.ac.uk), core funded by Cancer Research UK (www.cancerresearchuk.org), the largest independent cancer research organisation in the world.
Our Centre discovers, develops, validates and qualifies biomarkers in clinical studies and trials that detect cancer earlier and predict and monitor therapy responses to support optimised treatment of patients with cancer. Our advanced research programmes, agnostic to cancer type, develop biomarkers in tissue and less invasive clinical samples such as blood (liquid biopsy) with sophisticated bioinformatic and artificial intelligence solutions for multi-modal laboratory and clinical biomarker data analysis and interpretation. Our preclinical programmes focus on development of pharmacodynamic biomarker and evaluation the efficacy of novel therapeutics in patient derived models. As a bridge between discovery science and clinical research, we are highly collaborative across Manchester, nationally and internationally.
For any informal enquiries, please contact hannah.frost@cruk.manchester.ac.uk
Closing date: Sunday 11 August 2024 at 11:59pm.
Type / Role:
Subject Area(s):
Location(s):